Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
3,235.00
Year-over-Year Change
3.79%
Date Range
10/1/2000 - 1/1/2025
Summary
This economic indicator tracks depreciation, depletion, and amortization expenses for U.S. pharmaceutical and medicine corporations' property, plant, and equipment. It provides critical insights into capital investment, asset management, and long-term financial strategies within this key industry sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the systematic allocation of asset costs over their useful economic life for pharmaceutical companies. Economists use this metric to assess capital expenditure patterns, investment efficiency, and potential technological reinvestment in the pharmaceutical sector.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregating depreciation and amortization expenses across the industry.
Historical Context
This indicator helps policymakers and investors understand capital investment trends, technological innovation, and financial health in the pharmaceutical manufacturing industry.
Key Facts
- Tracks systematic allocation of asset costs in pharmaceutical manufacturing
- Provides insights into long-term capital investment strategies
- Reflects technological reinvestment and asset management efficiency
FAQs
Q: What does this economic indicator measure?
A: It measures depreciation, depletion, and amortization expenses for pharmaceutical companies' property, plant, and equipment, reflecting their capital investment strategies.
Q: Why is this trend important for investors?
A: It helps investors understand how pharmaceutical companies manage and invest in their physical assets, indicating potential future growth and technological innovation.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a consistent snapshot of the pharmaceutical industry's capital expenditure trends.
Q: What can this trend reveal about industry health?
A: It can indicate the sector's investment in new technologies, equipment upgrades, and overall financial resilience.
Q: Are there limitations to this economic indicator?
A: While valuable, the indicator only represents accounting expenses and should be analyzed alongside other financial metrics for a comprehensive understanding.
Related Trends
Quarterly Financial Report: U.S. Corporations: Paper: Cash and Demand Deposits in the U.S.
QFR201322USNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301TRAUSNO
Quarterly Financial Report: U.S. Corporations: Miscellaneous Manufacturing: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316339USNO
Quarterly Financial Report: U.S. Corporations: Telecommunications: Total Liabilities
QFRTL517USNO
Quarterly Financial Report: U.S. Corporations: All Information: Total Current Assets
QFRTCAINFUSNO
Quarterly Financial Report: U.S. Corporations: Scientific Research and Development Services: Other Short-Term Financial Investments
QFRD210547USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment [QFR102385USNO], retrieved from FRED.
Last Checked: 8/1/2025